NUFIP1 and Sepsis: These results suggest that NUFIP1-mediated ribophagy alleviates CD4+ T lymphocyte PANoptosis in sepsis via the cGAS-STING pathway, highlighting the therapeutic potential of targeting ribophagy and PANoptosis pathways to mitigate immune paralysis and improve the outcomes following septic insults.